Overview

Targeting Endoplasmic Reticulum Stress in Human Hypertension

Status:
RECRUITING
Trial end date:
2028-12-31
Target enrollment:
Participant gender:
Summary
There is strong evidence suggesting that endoplasmic reticulum stress contributes to neurogenic and vascular hypertension in various animal models, however this has never been explored in humans. Therefore, this project will fill this gap by performing a single-blind, placebo-controlled trial in humans with hypertension.
Phase:
PHASE1
Details
Lead Sponsor:
University of North Texas Health Science Center
Treatments:
ursodoxicoltaurine